Rare Glycogen Storage Diseases Natural History Study

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY

The purpose of this study is to collect and study key medical data about several ultra-rare GSDs (Glycogen Storage Diseases) including, but not limited to, GSD types 0a, 0b, VII, X, XII, XIII, XV, PRKAG2 syndrome and Danon disease.

Eligibility
Participation Requirements
Sex: All
Maximum Age: 90
Healthy Volunteers: f
View:

• Diagnosis of a rare GSD, including 0a, 0b, VII, X, XII, XIII, XV, PRKAG2 syndrome or Danon disease

‣ Two variants in the gene associated with the specific GSD type (for autosomal recessive diseases)

⁃ One variant in the gene associated with the specific GSD type (for autosomal dominant or X-linked diseases)

⁃ Deficient enzyme activity in liver, muscle, skin fibroblast or other tissue

⁃ One variant in causative gene with evidence of disease, per a clinician

⁃ Histology as confirmed by a clinician

• Able to provide informed consent for self (adults) or affected individual (minor or adults with a legally authorized representative)

• Able to provide consent for release of medical records

• Pregnant women with a diagnosis of a rare GSD will be included

Locations
United States
North Carolina
Duke University
RECRUITING
Durham
Contact Information
Primary
Rebecca Koch, PhD, RDN
rebecca.koch@duke.edu
919-681-8823
Backup
Nisha Dalal, MS, CCC-SLP
nisha.dalal@duke.edu
919-668-3107
Time Frame
Start Date: 2024-12-23
Estimated Completion Date: 2034-12
Participants
Target number of participants: 200
Treatments
Rare GSD (Glycogen Storage Disease)
individuals with confirmed diagnosis of rare glycogen storage disease including but not limited to, GSD types 0a, 0b, VII, X, XII, XIII, XV, PRKAG2 syndrome and Danon disease
Sponsors
Leads: Duke University

This content was sourced from clinicaltrials.gov

Similar Clinical Trials

We couldn't find any related articles check for more on the main search page.